[Clinical trial of a new substance with secretolytic action].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000814:Aniline Compounds / Q000627:therapeutic use*; D000996:Antitussive Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy; D001982:Bronchial Diseases / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy; D001996:Bronchopneumonia / Q000188:drug therapy; D005100:Expectorants / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011654:Pulmonary Edema / Q000188:drug therapy; D011656:Pulmonary Emphysema / Q000188:drug therapy; D012131:Respiratory Insufficiency / Q000188:drug therapy*; D014050:Toluene / Q000627:therapeutic use*
D000814:Aniline Compounds; D000996:Antitussive Agents; D005100:Expectorants; D014050:Toluene
Sperimentazione clinica di una nuova sostanza ad azione secretolitica.